T-REX 2X Long CRCL Daily Target ETFCCUP

The T-REX 2X Long CRCL Daily Target ETF (CCUP) debuted on Nasdaq this week with the subtlety of a T. rex in a china shop, complete with a 0.95% expense ratio that would make a hedge fund blush. The fund’s mandate is to deliver twice the daily return of the CRCL index, but the only thing doubling here is the fee you pay to own it. Nasdaq’s listing confirms the ticker is live and trading, yet it offers no glimpse of the basket beneath the hood, leaving investors to trust a wrapper that feels more like a filing trail stack than a growth engine.

CRCL is not a household name; it’s a benchmark so niche that its SEC filing reads like a secret society’s charter, with daily resets and leverage mechanics tucked into dense legalese. The ETF’s structure outsources the hard work to swap counterparties and futures desks, meaning the fund’s real engine is a fee stack that grows faster than the index it claims to amplify. There’s no evidence in the supplied rails that lists the top holdings, so investors are left guessing what they’re actually doubling down on each morning.

The issuer’s marketing sells volatility as a sport, but the fund itself is a daily-algebra machine wrapped in an expense ratio. The SEC EDGAR filing for CCUP confirms the fund exists under rule 6c-11, but it does not disclose holdings or swap terms, leaving the basket opaque even to those who pay the 0.95%. The FINRA Fund Analyzer labels CCUP as a daily-reset concentrated ETF but offers no visibility into the underlying contracts or collateral, reducing the wrapper to a black box you’re paying to open.

Charting CCUP’s moves is impossible without a chart route, and the supplied evidence does not include a TradingView link or any price history. What we do know is that the fund’s fee is the only thing guaranteed to compound daily, while the CRCL index’s daily target is anything but. Until the issuer publishes the basket or the swap terms, CCUP remains less an investment and more a bet on someone else’s filing discipline.

The evidence does not prove the fund’s holdings, swap counterparty names, or the CRCL index’s methodology beyond what’s buried in dense legalese. It also does not prove the fund’s liquidity, AUM size, or whether the 2X leverage resets cleanly on Nasdaq’s plumbing. What we do know is that the issuer markets CCUP as a high-octane play, yet the wrapper’s real job is to extract 0.95% per year for the privilege of not knowing what you own.